<DOC>
	<DOCNO>NCT00581932</DOCNO>
	<brief_summary>This study design identify genetic polymorphism ( also call allelic variant genetic marker ) associate response clozapine . This information use enhance understand clozapine response side effect . DNA patient examine significant association allelic variant candidate gene relation clozapine effect positive negative symptom , global response , quality life , relapse rate side effect .</brief_summary>
	<brief_title>Relationship Between Neurotransmitter Receptor Polymorphisms , Plasma Concentrations Clinical Response Clozapine</brief_title>
	<detailed_description>Patients age 18-65 DSM IV diagnosis schizophrenia history nonresponse conventional atypical antipsychotic treat clozapine psychiatrist , ask participate near time clozapine therapy initiate . The Brief Psychiatric Rating Scale ( BPRS ) , Scale Assessment Negative Symptoms ( SANS ) , Scale Assessment Positive Symptoms ( SAPS ) perform subject entry study , 3 week , 5 week , 8 week , 4 6 month . Adverse effect monitor Simpson-Angus Scale , Barnes Akathisia scale AIMS time point . The Calgary Depression Scale also administer visit . A complete neurocognitive assessment battery complete entry 6 month subject willing undergo neurocognitive testing . It anticipated subject complete neurocognitive testing . A blood cheek swab sample collect study entry DNA analysis . Plasma blood level collect week 3 , 5 , 8 study completion measurement clozapine plasma concentration . The subject 's weight , BMI , smoke status concomitant medication record visit .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Neurotransmitter Agents</mesh_term>
	<criteria>Diagnosis schizophrenia Beginning clozapine therapy age 1865 must willing participate interview provide DNA sample longer take clozapine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>clozapine , schizophrenia</keyword>
</DOC>